Entries by William Allbrook

,

Cellesce and Repositive collaborate to provide a searchable solution for finding cancer organoid models

Cellesce, has announced a collaboration with Repositive, which has developed the Cancer Models product, a searchable web-based platform, that connects cancer researchers to the models and services they need to drive research. The new partnership will expand the number of Repositive’s partners on Cancer Models to 12. Repositive’s integrated web-based solution, enables researchers to find […]

Joint Poster Presented at ELRIG Drug Discovery 2018

Horizon Discovery and Cellesce presented a joint poster at the ELRIG Drug Discovery Exhibition and Conference which took place 9th – 10th October in London. The last panel shows data confirming the activity of Trametinib  and demonstrating the differential effects of Dabrafenib from two lines of Cellesce expanded organoids. Both drugs, which can be used […]

,

Cellesce Collaborates with the National Physical Laboratory to Set New Standard for Organoid 3D Imaging

Cellesce is working in collaboration with the National Physical Laboratory (NPL), the UK’s National Measurement Institute, to image and analyse its range of colorectal cancer organoids. The collaboration is the result of a successful bid to ‘Analysis for Innovators’ – a £4M Innovate UK programme that offers access to funding and expertise to improve companies’ […]

,

Cellesce and Cardiff University win Innovate UK Primer Award to develop Organoids at scale to advance Breast Cancer Research

Cellesce and Cardiff University have won an Innovate UK competition. The award will fund a collaborative project that aims to improve research into scaling up organoids to enable the discovery of new breast cancer therapies. This project will build on the expertise the two teams have already established with colorectal cancer organoids. Organoids are three-dimensional […]

Cellesce Featured in Advances Journal

Cellesce has featured in the latest edition of ‘Advances,’ the journal for science, engineering and technology innovation in Wales. You can view and download the complete edition of  ‘Advances’ here. Images in the article are © Cellesce | NPL | M Squared Lasers

Cellesce Appoints Dr Mark Treherne as CEO

Cellesce has appointed Dr. Mark Treherne as its CEO. Mark, a veteran of the biotech industry, will lead the Company through the next phase of its development programme and commercialisation phase. Cellesce’s pioneering organoid expansion technology is focused on cancer research and compound library screening at scale for drug discovery. Mark obtained his PhD in […]

Cellesce Announces Fundraising to Grow its Cancer Organoid Business

Cellesce the cancer organoid bioprocessing and scale-up company has announced a successful six-figure funding round that will open up opportunities to introduce its organoid scale-up and expansion technology to the oncology drug discovery screening market. This funding round has, once again, been led by the Development Bank of Wales, a measure of the confidence it […]

Cancer organoids to model therapy response

Previously, we briefly commented on the interest generated by the significant study by Georgios Vlachogiannis and co-workers at the Institute of Cancer Research in London, “Patient-derived organoids model treatment response of metastatic gastrointestinal cancers.” This post looks in a bit more detail at this paper which was published in Science on February 23rd, and which […]

‘Mini-tumours’ created to battle cancer

The Today programme on BBC Radio 4 featured a news piece on Friday 23rd February 2018 which is a timely follow on to our previous news piece ‘Organoids – Method of the Year.’ The piece reported by the James Gallagher, the BBC’s Health and Science correspondent, focused on recent research where scientists have been able to predict […]

Organoids – Method of the Year

In the last few years fundamental cell biology research has moved from studies in two dimensions (2D) looking at cells on flat plastic plates to more comprehensive tools and understanding of how cells work in three dimensions (3D) both singly and in connection to other cells. 3D cell aggregates can be random constructs, or as […]